| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 32.464 | 41.675 | 75.373 | 137.091 | 238.952 | 51.058 |
| Total Income - EUR | - | - | - | - | 32.464 | 43.676 | 75.376 | 173.903 | 244.057 | 87.181 |
| Total Expenses - EUR | - | - | - | - | 4.523 | 9.000 | 30.847 | 127.590 | 150.042 | 132.730 |
| Gross Profit/Loss - EUR | - | - | - | - | 27.942 | 34.676 | 44.528 | 46.313 | 94.016 | -45.550 |
| Net Profit/Loss - EUR | - | - | - | - | 26.968 | 33.497 | 43.268 | 45.010 | 92.104 | -47.101 |
| Employees | - | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Neuroleadership Phd S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 59.253 | 103.573 | 182.168 | 308.594 | 517.222 | 556.494 |
| Current Assets | - | - | - | - | 21.726 | 24.787 | 54.807 | 75.188 | 240.931 | 52.186 |
| Inventories | - | - | - | - | 0 | 2.972 | -2.395 | 22.717 | 138.735 | 791 |
| Receivables | - | - | - | - | 10.144 | 17.201 | 51.356 | 50.225 | 100.078 | 50.444 |
| Cash | - | - | - | - | 11.582 | 4.614 | 5.846 | 2.246 | 2.118 | 951 |
| Shareholders Funds | - | - | - | - | 27.010 | 59.995 | 101.933 | 147.259 | 238.917 | 190.480 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 54.282 | 68.366 | 135.042 | 236.523 | 519.236 | 418.200 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6210 - 6210" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Neuroleadership Phd S.r.l.